These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19462469)

  • 1. Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems.
    Yoo SU; Krill SL; Wang Z; Telang C
    J Pharm Sci; 2009 Dec; 98(12):4711-23. PubMed ID: 19462469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.
    Pajula K; Taskinen M; Lehto VP; Ketolainen J; Korhonen O
    Mol Pharm; 2010 Jun; 7(3):795-804. PubMed ID: 20361760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
    Kini A; Patel SB
    Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
    Kushida I; Gotoda M
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid state drug-polymer miscibility studies using the model drug ABT-102.
    Jog R; Gokhale R; Burgess DJ
    Int J Pharm; 2016 Jul; 509(1-2):285-295. PubMed ID: 27265312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K; Sawicki W; Kozyra A; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
    Uchino T; Yasuno N; Yanagihara Y; Suzuki H
    Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I; Bates S; Chen P
    J Pharm Sci; 2009 Sep; 98(9):3373-86. PubMed ID: 19283767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved physical stability of amorphous state through acid base interactions.
    Telang C; Mujumdar S; Mathew M
    J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
    Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate.
    Higashi K; Hayashi H; Yamamoto K; Moribe K
    Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
    Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
    Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.